Sodium Zirconium Cyclosilicate (SZC)
D9487C00001
Phase 3 small_molecule terminated
Quick answer
Sodium Zirconium Cyclosilicate (SZC) for Hyperkalemia is a Phase 3 program (small_molecule) at AstraZeneca with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AstraZeneca
- Indication
- Hyperkalemia
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated